{"id":850,"date":"2024-03-18T19:05:48","date_gmt":"2024-03-18T19:05:48","guid":{"rendered":"https:\/\/www.socra.org\/blog\/?p=850"},"modified":"2024-03-21T17:46:39","modified_gmt":"2024-03-21T17:46:39","slug":"socras-first-ever-dct-conference","status":"publish","type":"post","link":"https:\/\/www.socra.org\/blog\/socras-first-ever-dct-conference\/","title":{"rendered":"Unlock the Future of Clinical Trials at SOCRA\u2019s First-Ever DCT Conference This April"},"content":{"rendered":"\n
\"\"<\/figure>
\n

Jessica Rowe, MA, MS, CCRP, CIP<\/p>\n\n\n\n

SOCRA President<\/p>\n<\/div><\/div>\n\n\n\n

Join us April 4-5, 2024, for this new program on Decentralized Clinical Trials (DCT) in charming Savannah, GA. Spearheaded by Jessica Rowe, President of SOCRA <\/a> and a passionate advocate for DCTs, this event is designed to clarify and explore the multifaceted world of DCTs. Over two days, attendees will gain comprehensive insights into the operational, regulatory, and ethical dimensions of DCTs, understanding how they are reshaping clinical research to be more inclusive and patient-centered.<\/p>\n\n\n\n\n\n\n\n

A Professional and <\/em>Personal Mission<\/h2>\n\n\n\n

The push toward DCTs is more than just a professional effort \u2013 it’s a deeply personal mission for Jess. Growing up in a resource-limited rural setting, Jess confronted firsthand the barriers to accessing advanced medical care and research. This personal experience has fueled her advocacy for DCTs, driving her to champion a shift in clinical research that prioritizes accessibility, inclusivity, and diversity. Jess’s advocacy for DCTs is driven by the belief that everyone, regardless of their geographic location, gender, race, sexual orientation, or socioeconomic status, deserves access to the latest medical advancements and the opportunity to contribute to scientific discoveries. In keeping with the medical community’s growing endorsement of a patient-centric approach, Jess advocates for a similar evolution in clinical research.<\/p>\n\n\n\n

“We’re transitioning our perspective to view patients as partners, not merely study subjects. Decentralizing clinical trials is about focusing on individuals and meeting them where they are,” Jess stated, emphasizing the need for clinical research to adapt and become more convenient and accessible to promote recruitment and retention.<\/p>\n\n\n\n

Through her leadership, the conference aims to showcase how DCTs can embody this vision, making clinical research universally accessible and reflective of a broad spectrum of populations and regions.<\/p>\n\n\n\n

Conference Highlights: A Gateway to DCT Expertise<\/h2>\n\n\n\n

Despite the clear advantages of recruitment, retention, diversity, and inclusivity, DCTs face considerable hurdles. Their novelty introduces complex challenges, and the absence of comprehensive regulatory guidance is a significant barrier to their broader implementation. Jess noted that many researchers remain cautious when navigating the uncertainties around technology, ethical considerations, and potential financial implications associated with departing from traditional trial models.<\/p>\n\n\n\n

To address these challenges and opportunities, the DCT conference has been carefully crafted to explore all aspects of DCTs, from ethical and regulatory considerations to practical implementation hurdles.<\/p>\n\n\n\n